-
BREAK EVEN ANALYSIS FOR CONTRACEPTION PRESCRIBING SERVICES IN COMMUNITY PHARMACIES
Feb 25, 2026, 14:40 PM -
DISPARITIES IN ACCESS TO MINIMALLY INVASIVE SURGERY - ASSESSING COMMUNITY NEED IN THE CASE OF CANCER INCIDENCE AND SURGICAL MODALITY
Feb 25, 2026, 14:40 PM -
ESTABLISHING VALIDITY AND DEVELOPING A PREDICTOR TOOL FOR ESTIMATION OF WILLINGNESS TO PAY BASED THRESHOLD FOR INDIA
Feb 25, 2026, 14:40 PM -
WHAT CAN SOCIAL DRIVERS OF HEALTH DATA TELL US ABOUT HEALTH PLAN MEMBERS IN A LARGE REAL-WORLD DATABASE?
Feb 25, 2026, 14:40 PM -
WHEN TIMING CHANGES: SEASONAL TRENDS IN U.S. UROLOGIC PROCEDURE UTILIZATION
Feb 25, 2026, 14:40 PM -
AUTOMATING EVIDENCE GAP ANALYSIS USING A MULTI-AGENT AI FRAMEWORK: A MASH CASE STUDY
Feb 25, 2026, 14:40 PM -
HEALTHCARE COSTS ASSOCIATED WITH OBESITY-RELATED CONDITIONS AND COMORBIDITIES AMONG U.S. ADULTS WITH OVERWEIGHT OR OBESITY
Feb 25, 2026, 14:40 PM -
DISPARITY IMPLICATIONS OF MACHINE-LEARNING-BASED MTM ELIGIBILITY CRITERIA
Feb 25, 2026, 14:40 PM -
IMPROVING REAL-WORLD ADOPTION OF HER2-LOW THERAPIES THROUGH TARGETED EDUCATIONAL INITIATIVES
Feb 25, 2026, 14:40 PM -
EFFICACY OF PANITUMUMAB VS. CETUXIMAB PLUS CHEMOTHERAPY IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK: AN ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON
Feb 25, 2026, 14:40 PM -
TRENDS IN DIABETIC KETOACIDOSIS INCIDENCE AMONG NEW USERS OF SGLT2 INHIBITORS FOLLOWING EXPANDED INDICATIONS, 2020-2023
Feb 25, 2026, 14:40 PM -
100% WHEY PEPTIDE-BASED FORMULAS COMPARED TO POLYMERIC ENTERAL NUTRITION AMONG CHILDREN RECEIVING HOME ENTERAL NUTRITION: A COST-BENEFIT ANALYSIS
Feb 25, 2026, 14:40 PM -
CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS
Feb 25, 2026, 14:40 PM -
ARE EXTERNAL CONTROL ARMS PATIENT CENTRIC?
Feb 25, 2026, 14:40 PM -
ADVANCING SURVIVAL ANALYSIS AUTOMATION FOR HTA SUBMISSIONS: A MULTI-AGENTIC GENERATIVE AI FRAMEWORK
Feb 25, 2026, 14:40 PM -
INTEGRATING PATIENT- AND OBSERVER-REPORTED OUTCOMES INTO VALUE ASSESSMENT FOR PEDIATRIC NEUROBLASTOMA
Feb 25, 2026, 14:40 PM -
DIRECT MEDICAL COSTS SAVED BY EARLY PAH DETECTION USING A MACHINE LEARNING ALGORITHM
Feb 25, 2026, 14:40 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEPATITIS DELTA VIRUS RNA-BASED SURROGATE ENDPOINTS AND LONG-TERM CLINICAL OUTCOMES IN HEPATITIS DELTA VIRUS INFECTION: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:40 PM -
COST-EFFECTIVENESS AS THE NEXT POLICY LEVER IN THE UNITED STATES? IMPLICATIONS FOR PHARMACEUTICAL PRICING IN A POST-MFN LANDSCAPE
Feb 25, 2026, 14:40 PM -
HYPERTENSION CONTROL IN TREATED U.S. CANCER SURVIVORS UNDER THE 2017 ACC/AHA GUIDELINE: AN ANALYSIS OF NHANES 2011-2023
Feb 25, 2026, 14:40 PM
